Abstract

INTRODUCTION: Globally, women are diagnosed with breast cancer more often than any other cancer. Precise lymph node staging is crucial for the prognosis and treatment of patients with breast cancer. The invasion status of the lymphatic region draining the damaged organ would be reflected in a study of this SLN. Only in cases where the SLN is the location of metastases is LN dissection carried out. In breast cancer patients who are node negative during pre-operative clinical examination and imaging, SLNB has become the standard treatment for axillary staging since the groundbreaking experiences with both radioisotope (RI) and Blue Dye (BD). Superparamagnetic iron oxide (SPIO), microbubbles, and indocyanine green (ICG) are some of the new tracers that have been used in clinical practice. There is mounting proof that SLNB with ICG for breast cancer is both safe and practical. The aim of this study was to provide an update on this SLN technique in with objective to assess its efficacy, safety and as tool to avoid axillary lymph node dissection. (ALND).

Description